# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-12-265222
Filing Date
2012-06-08
Accepted
2012-06-08 16:36:56
Documents
11
Period of Report
2012-06-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | d364463d6k.htm | 6-K | 11222
2 | PRESS RELEASE | d364463dex991.htm | EX-99.1 | 7248
3 | PRESS RELEASE | d364463dex992.htm | EX-99.2 | 5817
4 | INVESTOR UPDATE | d364463dex993.htm | EX-99.3 | 26858
5 | GRAPHIC | g364463g11k91.jpg | GRAPHIC | 303435
6 | GRAPHIC | g364463g26w55.jpg | GRAPHIC | 291028
7 | GRAPHIC | g364463g37q61.jpg | GRAPHIC | 352352
8 | GRAPHIC | g364463g48f73.jpg | GRAPHIC | 318014
9 | GRAPHIC | g364463g62m31.jpg | GRAPHIC | 309546
10 | GRAPHIC | g364463g67e02.jpg | GRAPHIC | 308655
11 | GRAPHIC | g364463g78v31.jpg | GRAPHIC | 24835
| Complete submission text file | 0001193125-12-265222.txt |  | 2681758

Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 12898275
SIC: 2834 Pharmaceutical Preparations